sulpiride has been researched along with Diabetes Mellitus, Type 1 in 4 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study first demonstrates that levosulpiride has an accelerating effect on the emptying of solids from the stomach of patients with diabetic gastroparesis." | 9.08 | Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. ( De Martini, D; Mansi, C; Mela, GS; Melga, P; Perilli, D; Savarino, V; Sciabà, L; Vigneri, S, 1995) |
| "Our results show the importance of gastric emptying in the maintenance of glycemic control and the usefulness of chronic administration of levosulpiride in diabetic subjects with gastroparesis." | 9.08 | Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. ( Ciuchi, E; Giusti, R; Mansi, C; Melga, P; Prando, R; Sciaba, L, 1997) |
| "Our study first demonstrates that levosulpiride has an accelerating effect on the emptying of solids from the stomach of patients with diabetic gastroparesis." | 5.08 | Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. ( De Martini, D; Mansi, C; Mela, GS; Melga, P; Perilli, D; Savarino, V; Sciabà, L; Vigneri, S, 1995) |
| "Our results show the importance of gastric emptying in the maintenance of glycemic control and the usefulness of chronic administration of levosulpiride in diabetic subjects with gastroparesis." | 5.08 | Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. ( Ciuchi, E; Giusti, R; Mansi, C; Melga, P; Prando, R; Sciaba, L, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, H | 1 |
| Mikami, R | 1 |
| Yonemochi, N | 1 |
| Waddington, JL | 1 |
| Melga, P | 3 |
| Mansi, C | 3 |
| Savarino, V | 1 |
| Vigneri, S | 1 |
| Perilli, D | 1 |
| Sciabà, L | 2 |
| De Martini, D | 1 |
| Mela, GS | 1 |
| Ciuchi, E | 1 |
| Giusti, R | 1 |
| Prando, R | 1 |
3 trials available for sulpiride and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Type 1 (insulin-dependent) diabetes mellitus and gastric emptying: role of blood glucose concentration and dopamine D2 receptors.
Topics: Adult; Blood Glucose; Breath Tests; Cisapride; Cross-Over Studies; Diabetes Mellitus, Type 1; Female | 2004 |
Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.
Topics: Cross-Over Studies; Diabetes Mellitus, Type 1; Dopamine Antagonists; Double-Blind Method; Dyspepsia; | 1995 |
Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis.
Topics: Administration, Oral; Adult; Autonomic Nervous System Diseases; Blood Glucose; Diabetes Mellitus, Ty | 1997 |
1 other study available for sulpiride and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Regulation of plasma glucose levels by central dopamine D
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dopamine; Dopami | 2023 |